Ashley M Brigham, PHARMD | |
400 Cochituate Rd, Target Pharmacy, Framingham, MA 01701-4655 | |
(508) 628-6004 | |
(508) 628-6004 |
Full Name | Ashley M Brigham |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 400 Cochituate Rd, Framingham, Massachusetts |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417242512 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | PH232548 (Massachusetts) | Primary |
Mailing Address | Practice Location Address |
---|---|
Ashley M Brigham, PHARMD 400 Cochituate Rd, Target Pharmacy, Framingham, MA 01701-4655 Ph: (508) 628-6004 | Ashley M Brigham, PHARMD 400 Cochituate Rd, Target Pharmacy, Framingham, MA 01701-4655 Ph: (508) 628-6004 |
News Archive
A shorter anti-malaria treatment is as effective in treating seriously ill children as the standard regimen, according to new research. Researchers have shown that three doses over two days of the drug artesunate are as effective in killing the malaria parasite in the blood as five doses over three days.
Tissue engineers create artificial organs and tissues that can be used to develop and test new drugs, repair damaged tissue and even replace entire organs in the human body. However, current fabrication methods limit their ability to produce free-form shapes and achieve high cell viability.
Cephalon, Inc. today announced that the company received a second Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the supplemental new drug application (sNDA) for NUVIGIL(R) (armodafinil) Tablets [C-IV] for the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel. In its letter to the company, the FDA reiterated its previously stated concerns regarding the NUVIGIL sNDA.
As part of an international research project, a team of researchers has developed a DNA clamp that can detect mutations at the DNA level with greater efficiency than methods currently in use. Their work could facilitate rapid screening of those diseases that have a genetic basis, such as cancer, and provide new tools for more advanced nanotechnology. The results of this research is published this month in the journal ACS Nano.
› Verified 3 days ago
Katie Schmidt, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 776 Water St, Framingham, MA 01701 Phone: 508-877-2600 | |
Anthony Michael D'urso, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 121 Worcester Rd, Framingham, MA 01701 Phone: 508-872-4265 | |
Manhal Totonchy, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 235 Old Connecticut Path, Framingham, MA 01701 Phone: 508-820-0903 | |
Purvi Patel, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 15 School St, Framingham, MA 01701 Phone: 508-788-0604 Fax: 508-788-3659 | |
Karen Linnea Obarowski, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1280 Worcester Rd, Framingham, MA 01702 Phone: 339-221-1239 | |
John Michael Lavoie, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1280 Worcester Rd, Framingham, MA 01702 Phone: 508-872-1432 | |
Sofiya Abraham, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4 Bishop St, 304, Framingham, MA 01702 Phone: 203-565-5205 |